The DOI matches its Crossref record; 138 of the 140 references it cites were found in a registry or an index.
Oxidative Stress and the Pathogenesis of Alzheimer's Disease
Open accessAbstract
Alzheimer's disease (AD) is the most common neurodegenerative disease that causes dementia in the elderly. Patients with AD suffer a gradual deterioration of memory and other cognitive functions, which eventually leads to a complete incapacity and death. A complicated array of molecular events has been implicated in the pathogenesis of AD. The major pathological characteristics of AD brains are the presence of senile plaques, neurofibrillary tangles, and neuronal loss. Growing evidence has demonstrated that oxidative stress is an important factor contributing to the initiation and progression of AD. However, the mechanisms that lead to the disruption of redox balance and the sources of free radicals remain elusive. The excessive reactive oxygen species may be generated from mechanisms such as mitochondria dysfunction and/or aberrant accumulation of transition metals, while the abnormal accumulation of Abeta and tau proteins appears to promote the redox imbalance. The resulted oxidative stress has been implicated in Abeta- or tau-induced neurotoxicity. In addition, evidence has suggested that oxidative stress may augment the production and aggregation of Abeta and facilitate the phosphorylation and polymerization of tau, thus forming a vicious cycle that promotes the initiation and progression of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the context of Aβ production, multiple investigations have revealed that oxidative stress leads to the formation of SPs by lowering α-secretase activity while increasing both βand γ-secretase activities [52].”
From Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer’s Disease: Preclinical to Clinical Trial Insights (2023) · cites this paper as [52]
In the citing paper
“However, when the hyperphosphorylated Tau protein is overexpressed (which is a pathophysiological indicator of AD) a depletion of these organelles has been evidenced, suggesting it is the cause of H2O2 and ROS increase [72,108,126].”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [126]
In the citing paper
“Hydrogen peroxide seems to be the relevant actor in promoting excessive oxidation in neuronal cells.”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [126]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M. J., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K. S., Hasegawa, K., Hendrie, H. C., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,336
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
A Century of Alzheimer's Disease
Goedert, M., & Spillantini, M. G. (2006) · Science · doi:10.1126/science.1132814 · Cited by 2,153
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611
Flagged first, then by citations
2 of the 140 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 863
Chandrasekaran, S., & Bonchev, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0144052 · Cited by 24
Relationship Between β-Amyloid and Mitochondrial Dynamics
Kim, D. I., Lee, K. H., Oh, J. Y., Kim, J. S., & Han, H. J. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0434-4 · Cited by 23
Prasansuklab, A., Theerasri, A., Payne, M. S., Ung, A. T., & Tencomnao, T. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2288-4 · Cited by 23
The Mitochondrion: A Potential Therapeutic Target for Alzheimer’s Disease
Lu, M., Zhao, X., Yao, P.-P., Xu, D.-E., & Ma, Q. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0310-y · Cited by 23
Katayama, H. (2019) · Brain and Behavior · doi:10.1002/brb3.1504 · Cited by 24
Salcedo, C., Wagner, A., Andersen, J. V., Vinten, K. T., Waagepetersen, H. S., Schousboe, A., Freude, K., & Aldana, B. I. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03276-3 · Cited by 28
Therapeutic approaches of nutraceuticals in the prevention of Alzheimer's disease
Pandey, S. N., Singh, G., Semwal, B. C., Gupta, G., Alharbi, K. S., Almalki, W. H., Albratty, M., Najmi, A., & Meraya, A. M. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14426 · Cited by 23
Kyosseva, S. V. (2015) · World Journal of Ophthalmology · doi:10.5318/wjo.v5.i1.23 · Cited by 22
Oxidative Stress Assessment in Alzheimer’s Disease: A Clinic Setting Study
Vergallo, A., Giampietri, L., Baldacci, F., Volpi, L., Chico, L., Pagni, C., Giorgi, F. S., Ceravolo, R., Tognoni, G., Siciliano, G., et al. (2017) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317517728352 · Cited by 24
Advancements in Targeting Ion Channels for the Treatment of Neurodegenerative Diseases
Li, Y., Fu, J., & Wang, H. (2024) · Pharmaceuticals · doi:10.3390/ph17111462 · Cited by 21
Kim, J., Lim, D.-K., Suh, Y., & Chang, K. (2021) · Antioxidants · doi:10.3390/antiox10081321 · Cited by 20
Camacho, L., Phillips-Farfán, B. V., Rosas-Mendoza, G., Baires-López, A., Toral-Ríos, D., Campos‐Peña, V., & Carvajal, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-98983-w · Cited by 21
The NLRP3 Inflammasome in the Pathogenesis and Treatment of Alzheimer’s Disease
Golzari-Sorkheh, M., Brown, C. E., Weaver, D. F., & Reed, M. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210660 · Cited by 21
Synthetic Mono-Carbonyl Curcumin Analogues Attenuate Oxidative Stress in Mouse Models
Hussain, H., Ahmad, S., Shah, S. W. A., Ullah, A., Rahman, S. U., Ahmad, M., Almehmadi, M. M., Abdulaziz, O., Allahyani, M. A., Alsaiari, A. A., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10102597 · Cited by 21
Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective
Ferrer, I. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3806 · Cited by 25
Long, T., Chen, X., Zhang, Y., Zhou, Y., He, Y.-N., Zhu, Y., Fu, H., Yu, L., Yu, C., Law, B. Y. K., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115261 · Cited by 21
Current Advances in Mitochondrial Targeted Interventions in Alzheimer’s Disease
de Sousa, T. S., Moreira, P. I., & Cardoso, S. (2023) · Biomedicines · doi:10.3390/biomedicines11092331 · Cited by 22
Amyloid Beta Influences Vascular Smooth Muscle Contractility and Mechanoadaptation
Hald, E. S., Timm, C. D., & Alford, P. W. (2016) · Journal of Biomechanical Engineering · doi:10.1115/1.4034560 · Cited by 21
Bhatia, G., Dhuna, V., Dhuna, K., Kaur, M., & Singh, J. V. (2017) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(18)30017-7 · Cited by 21
The impact of anorexigenic peptides in experimental models of Alzheimer’s disease pathology
Maletı́nská, L., Popelová, A., Železná, B., Bencze, M., & Kuneš, J. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0532 · Cited by 21
Pathogenic or protective? Neuropeptide Y in amyotrophic lateral sclerosis
Clark, C. M., Clark, R. M., Hoyle, J. A., & Dickson, T. C. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15125 · Cited by 20
Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease
Bu, X., Jiao, S., Lian, Y., & Wang, Y. (2015) · Current Alzheimer Research · doi:10.2174/1567205013666151215110114 · Cited by 20
Cheignon, C., Hureau, C., & Collin, F. (2017) · Inorganica Chimica Acta · doi:10.1016/j.ica.2017.07.031 · Cited by 21
Natarajan, S., Govindaraju, A., Rajmohamed, M., Palanisamy, P., & Abdulkader, A. (2017) · Pharmacognosy Magazine · doi:10.4103/pm.pm_57_17 · Cited by 20
The role of reactive oxygen species in the regulation of the blood-brain barrier
Shuvalova, M. L., Dmitrieva, A., Belousov, V. V., & Nosov, G. (2024) · Tissue Barriers · doi:10.1080/21688370.2024.2361202 · Cited by 21
Yin, J., & Horzmann, K. A. (2024) · Biomedicines · doi:10.3390/biomedicines12071559 · Cited by 20
Decoding NLRP3 Inflammasome Activation in Alzheimer’s Disease: A Focus on Receptor Dynamics
Maurya, R., Sharma, A., & Naqvi, S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04918-1 · Cited by 22
Massaccesi, L., Galliera, E., Galimberti, D., Fenoglio, C., Arcaro, M., Goi, G., Barassi, A., & Romanelli, M. M. C. (2019) · Immunity & Ageing · doi:10.1186/s12979-019-0147-x · Cited by 20
Qu, Y.-J., Ding, M.-R., Gu, C., Zhang, L., Zhen, R.-R., Chen, J.-F., Hu, B., & An, H. (2022) · Pharmaceutical Biology · doi:10.1080/13880209.2022.2098344 · Cited by 19
Manta, K., Papakyriakopoulou, P., Nikolidaki, A., Balafas, E., Kostomitsopoulos, N. G., Banella, S., Colombo, G., & Valsami, G. N. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082036 · Cited by 22
Modification of Tau by 8-Nitroguanosine 3′,5′-Cyclic Monophosphate (8-Nitro-cGMP)
Yoshitake, J., Soeda, Y., Ida, T., Sumioka, A., Yoshikawa, M., Matsushita, K., Akaike, T., & Takashima, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.734350 · Cited by 20
Nday, C. M., Eleftheriadou, D., & Jackson, G. E. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14256 · Cited by 21
Lin, X., Yao, M., Lu, J., Wang, Y., Yin, X., Liang, M., Yuan, E., & Ren, J. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.06.014 · Cited by 21
Nannelli, G., Ziche, M., Donnini, S., & Morbidelli, L. (2020) · Biomedicines · doi:10.3390/biomedicines8010004 · Cited by 20
Exploring the role of mitochondrial proteins as molecular target in Alzheimer’s disease
Chadha, S., Behl, T., Sehgal, A., Kumar, A., & BUNGAU, S. G. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.11.008 · Cited by 20
Hsu, H., Chang, W.-M., Wu, J., Huang, C.-C., Lu, F., Chuang, Y.-W., Chang, P., Chen, K.-H., Hong, C., Yeh, R.-H., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146440 · Cited by 20
Potential Roles of Natural Antioxidants in Modulating Neurodegenerative Disease Pathways
Oyovwi, M. O., Agbonifo‐Chijiokwu, E., Ben‐Azu, B., Atere, A. D., Joseph, G. U., Godsday, O. U., & Udi, O. A. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04874-w · Cited by 21
Exploring unexplored biomarkers of oxidative distress and their use
Thakkar, H., Eerla, R., Gangakhedkar, S., & Shah, R. P. (2021) · Advances in Redox Research · doi:10.1016/j.arres.2021.100020 · Cited by 19
Neuroprotective Effects of Myrtenal in an Experimental Model of Dementia Induced in Rats
Dragomanova, S., Pavlov, S. P., Marinova, D., Hodzev, Y., Petralia, M., Fagone, P., Nicoletti, F., Lazarova, M., Tzvetanova, E., Alexandrova, A., et al. (2022) · Antioxidants · doi:10.3390/antiox11020374 · Cited by 20
Patel, P., & Shah, J. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01086-2 · Cited by 19
The Role of Dietary Antioxidants and Their Potential Mechanisms in Alzheimer’s Disease Treatment
Knight, E., Geetha, T., Broderick, T. L., & Babu, J. R. (2023) · Metabolites · doi:10.3390/metabo13030438 · Cited by 20
Using Redox Proteomics to Gain New Insights into Neurodegenerative Disease and Protein Modification
Cadenas-Garrido, P., Schonvandt-Alarcos, A., Herrera‐Quintana, L., Vázquez‐Lorente, H., Santamaría-Quiles, A., de Francisco, J. R., Moya-Escudero, M., Martín‐Oliva, D., Martín-Guerrero, S. M., Rodríguez-Santana, C., et al. (2024) · Antioxidants · doi:10.3390/antiox13010127 · Cited by 20
Age-related macular degeneration and Alzheimer disease
Çerman, E., Eraslan, M., & Çekıç, O. (2015) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1406-146 · Cited by 19
Vališ, M., Herman, D. P., Váňová, N., Masopust, J., Vyšata, O., Hort, J., Pavelek, Z., Klímová, B., Kuča, K., Misík, J., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00943 · Cited by 20
Sharma, H. K., Borah, S., & Sarkar, P. (2020) · Pharmacognosy Research · doi:10.4103/pr.pr_84_19 · Cited by 20
Yeast Model of Amyloid-β and Tau Aggregation in Alzheimer’s Disease
Moosavi, B., Mousavi, B., & Macreadie, I. G. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150173 · Cited by 19
Zhang, R., Zhang, L., Zhang, L., Wang, Y., & Li, L. (2018) · Journal of Natural Medicines · doi:10.1007/s11418-018-1177-y · Cited by 19
Kaur, P., Khan, H., Grewal, A. K., Dua, K., Singh, S. K., Gupta, G., & Singh, T. G. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273321002240919102841 · Cited by 19
Nanomedicine against Alzheimer’s and Parkinson’s Disease
Tandon, A., Singh, S. J., & Chaturvedi, R. K. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201021140904 · Cited by 20
Molecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer’s disease
Khan, F. Z., Mostaid, M. S., & Apu, M. N. H. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09874 · Cited by 20
POPOVICI, L.-F., Brinza, I., Gatea, F., Badea, G. I., Vamanu, E., Oancea, S., & Hriţcu, L. (2025) · Antioxidants · doi:10.3390/antiox14010097 · Cited by 20
Antioxidants in anti‐Alzheimer's disease drug discovery
Guo, J., Zhu, Y., Zhi, J., Lou, Q., Bai, R., & He, Y. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102707 · Cited by 21
Clinical benefits of green tea consumption for cognitive dysfunction
Ide, K., & Yamada, H. (2015) · PharmaNutrition · doi:10.1016/j.phanu.2015.07.001 · Cited by 19
Direct Interaction between Selenoprotein P and Tubulin
Du, X., Qiu, S., Wang, Z., Wang, R., Wang, C., Tian, J., & Liu, Q. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150610199 · Cited by 18
Meng, F., Li, J., Rao, Y., Wang, W., & Fu, Y. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/7480980 · Cited by 18
Nawaz, A., Batool, Z., Shazad, S., Rafiq, S., Afzal, A., & Haider, S. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.05.049 · Cited by 20
Babür, E., Tan, B., Yousef, M., Cinbaş, S., Süer, C., & Dursun, N. (2019) · Biological Trace Element Research · doi:10.1007/s12011-019-01666-x · Cited by 18
Gout and the risk of Alzheimer′s disease: A Mendelian randomization study
Lee, Y. H. (2019) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13548 · Cited by 18
Joo, S. H., Hahn, C., Lim, H. K., Yoon, K. D., Yoon, S. H., & Lee, C. U. (2019) · Psychiatry Investigation · doi:10.30773/pi.2019.06.17 · Cited by 19
Homolak, J., Busscher, J. D., Zambrano-Lucio, M., Joja, M., Virag, D., Perhoč, A. B., Knezović, A., Barilar, J. O., & Šalković‐Petrišić, M. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00223 · Cited by 18
Coloured Compounds in Fruits and Vegetables and Health
Deis, L., Quiroga, A. M., & Rosas, M. I. D. (2021) · Springer eBooks · doi:10.1007/978-3-030-61721-9_25 · Cited by 19
Liu, Y., Tang, K., Cai, W., Chen, A., Zhou, G., Li, L., & Liu, R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.918462 · Cited by 17
Hao, C., Han, M., Wang, W., Yang, C., Wang, J., Guo, Y., Xu, T., Zhang, L., & Li, C. (2023) · Marine Life Science & Technology · doi:10.1007/s42995-023-00172-3 · Cited by 20
Agarwal, T., Manandhar, S., Kumar, H., Famurewa, A. C., Gurram, P. C., Shri, S. R., Sankhe, R., Mudgal, J., & Pai, K. S. R. (2024) · Scientific Reports · doi:10.1038/s41598-024-57188-7 · Cited by 17
Yilmazer, U. T., Pehlivan, B., Güney, Ş., Sağlam, A. S. Y., Balabanlı, B., Kaltalıoğlu, K., & Coskun-Cevher, S. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115131 · Cited by 17
Peptide-based inhibitors and nanoparticles: Emerging therapeutics for Alzheimer’s disease
Mojarad-Jabali, S., & Roh, K. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.125055 · Cited by 17
The emerging role of oxygen redox in pathological progression of disorders
Li, S.-Y., Gong, X., Ndikuryayo, F., & Yang, W. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102660 · Cited by 17
Chang, C., Hu, W.-C., Shen, C.-P., Hsu, B., Lin, W., Sung, P., Wang, W., Wu, J., & Kuo, Y. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034608 · Cited by 17
Park, J. W., Kim, J. E., Kang, M. J., Choi, H. J., Bae, S. J., Kim, S. H., Jung, Y. S., Hong, J. T., & Hwang, D. Y. (2019) · Antioxidants · doi:10.3390/antiox8100450 · Cited by 17
Barchiesi, A., Bazzani, V., Tolotto, V., Elancheliyan, P., Wasilewski, M., Chacińska, A., & Vascotto, C. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.11.012 · Cited by 17
Guo, G., Fan, L., Yan, Y., Xu, Y., Deng, Z., Tian, M., Geng, Y., Xia, Z., & Xu, Y. (2023) · Scientific Data · doi:10.1038/s41597-023-02512-5 · Cited by 18
Rastinpour, Z., Fakhri, S., Abbaszadeh, F., Ranjbari, M., Kiani, A., Amin, M. N., & Echeverría, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1589751 · Cited by 16
Importance of Oxidative Stress and Antioxidant System in Health and Disease
Sabuncuoğlu, S., & Yalçınkaya, A. S. (2022) · Biochemistry · doi:10.5772/intechopen.100949 · Cited by 16
Czarnecka, K., Girek, M. K., Kręcisz, P., Skibiński, R., Łątka, K., Jończyk, J., Bajda, M., Szymczyk, P., Galita, G., Kabziński, J., et al. (2023) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2022.2158822 · Cited by 16
Xie, D., Deng, T., Zhai, Z., Qin, T., Song, C., Xu, Y., & Sun, T. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114290 · Cited by 16
RetractedLuo, Z., Li, S., Zhang, Y., Yin, F., Luo, H., Chen, X., Cui, N., Wan, S., Li, X., Kong, L., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115415 · Cited by 16
Gul, S., Attaullah, S., Alsugoor, M. H., Bawazeer, S., Shah, S. A., Khan, S., Salahuddin, H. S., & Ullah, M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16930 · Cited by 17
Li, J., Chen, L., Liu, S., Sun, Y., Zhen, L., Zhu, Z., Wang, G., & Li, X. (2023) · Cells · doi:10.3390/cells12192348 · Cited by 18
Aldayel, T. S., El-Hak, H. N. G., Nafie, M. S., Saad, R., Abdelrazek, H. M. A., & Kilany, O. E. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04279-z · Cited by 16
Bir, A., Ghosh, A., Chauhan, A., Saha, S., Saini, A. K., Bisaglia, M., & Chakrabarti, S. (2024) · Antioxidants · doi:10.3390/antiox13030316 · Cited by 18
Antioxidants in the Prevention and Treatment of Alzheimer’s Disease
Singh, S. K., Srikrishna, S., Castellani, R. J., & Perry, G. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-67625-8_20 · Cited by 16
Protective effect of Berberis vulgaris on Fenton reaction-induced DNA cleavage.
Asadi, N. S., Heidari, M., & Khatami, M. (2019) · PubMed Central · doi:10.22038/ajp.2018.11788 · Cited by 16
Casaril, A. M., Domingues, M., Lourenço, D. D. A., Vieira, B. M., Begnini, K. R., Corcini, C. D., França, R. T., Varela, A. S., Seixas, F. K., Collares, T. V., et al. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109278 · Cited by 16
Niederschweiberer, M. A., Schaefer, P. M., Singh, L. N., Lausser, L. M., Bhosale, D., Hesse, R., Calzia, E., Kestler, H. A., Rueck, A. C., Wallace, D. C., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.671274 · Cited by 18
Milanizadeh, S., Zuwarali, K. N. N., Aliaghaei, A., & Bigdeli, M. R. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1054-x · Cited by 16
Zhao, J., Zeng, Y., Wang, Y., Shi, J., Zhao, W., Wu, B., & Du, H. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1769617 · Cited by 17
The endocannabinoid system: a bridge between alzheimer’s disease and gut microbiota
Bisogno, T., Lauritano, A., & Piscitelli, F. (2021) · Life · doi:10.3390/life11090934 · Cited by 16
Park, M., Kim, S.-H., & Lee, H. (2021) · Applied Sciences · doi:10.3390/app11125654 · Cited by 15
Rojas-Solé, C., Pinilla-González, V., Lillo‐Moya, J., González-Fernández, T., Saso, L., & Rodrigo, R. (2023) · Redox Report · doi:10.1080/13510002.2023.2289740 · Cited by 21
Multi‐Targeting Phytochemicals for Alzheimer's Disease
Bhattacharya, R. S., Singh, R., Panghal, A., Thakur, A., Singh, L., Verma, R. K., Singh, C., Goyal, M., & Kumar, J. (2025) · Phytotherapy Research · doi:10.1002/ptr.8435 · Cited by 18
Genistein: A promising ally in combating neurodegenerative disorders
Sharma, D., Singh, V., Kumar, A., & Singh, T. G. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177273 · Cited by 15
PhIP exposure in rodents produces neuropathology potentially relevant to Alzheimer’s disease
Syeda, T., Foguth, R. M., Llewellyn, E., & Cannon, J. R. (2020) · Toxicology · doi:10.1016/j.tox.2020.152436 · Cited by 15
Boswellic Acids as Promising Leads in Drug Development against Alzheimer’s Disease
Haghaei, H., Soltani, S., Hosseini, S. R. A., Rashidi, M., & Karima, S. (2020) · Pharmaceutical Sciences · doi:10.34172/ps.2020.25 · Cited by 16
Glutathione S-transferases variants as risk factors in Alzheimer’s disease
Wang, T. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2245-7 · Cited by 15
Zhao, B., & Zhao, B. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.02.010 · Cited by 15
Self-citationInherent potential of mitochondria-targeted interventions for chronic neurodegenerative diseases
Zhou, M., Zheng, M., Liang, S., Li, M., Ma, J., Zhang, S., Song, X., Hu, Y., Lyu, Y., Ou, X., et al. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01507 · Cited by 18
Li, N., Pang, Q., Zhang, Y., Lin, J., Li, H., Li, Z., Liu, Y., Fang, X., An, Y., Bai, H., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1103012 · Cited by 14
Atoki, A. V., Aja, P. M., Ondari, E. N., & Shinkafi, T. S. (2023) · International Journal of Food Properties · doi:10.1080/10942912.2023.2243050 · Cited by 20
Marsh, D. T., Sugiyama, A., Imai, Y., Kato, R., & Smid, S. D. (2023) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13943 · Cited by 14
Wen, Q., Wittens, M. M. J., Engelborghs, S., van Herwijnen, M. H. M., Tsamou, M., Roggen, E., Smeets, H. J. M., Krauskopf, J., & Briedé, J. J. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00740 · Cited by 14
Metadata
- Authors
- Zhao, Y., & Zhao, B.
- Affiliations
- Harbin Institute of Technology (CN)
- Chinese Academy of Sciences (CN)
- Corresponding author
- Zhao, Yan
- Zhao, Baolu
- ORCID
- Zhao, Yan
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-10
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- PMC
- PMC3745981
- OpenAlex
- W2141262291
- Cited by
- 855
- References
- 140
- Citations by year
- 2026: 47 · 2025: 61 · 2024: 82 · 2023: 78 · 2022: 80 · 2021: 83 · 2020: 76 · 2019: 71 · 2018: 64 · 2017: 64 · 2016: 53 · 2015: 54 · 2014: 36 · 2013: 5
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Oxidative Medicine and Cellular Longevity (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (30930036, 31201338, 30870587, 2009-3-93, 2011DXGJ14, Y200902, 2009147, 2006CB500706)
- Weihai Science and Technology Development Program (30930036, 31201338, 30870587, 2009-3-93, 2011DXGJ14, Y200902, 2009147, 2006CB500706)
- Harbin Institute of Technology (30930036, 31201338, 30870587, 2009-3-93, 2011DXGJ14, Y200902, 2009147, 2006CB500706)
- National Basic Research Program of China (30930036, 31201338, 30870587, 2009-3-93, 2011DXGJ14, Y200902, 2009147, 2006CB500706)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- Alzheimer's disease, oxidative stress, redox imbalance, reactive oxygen species, free radicals, mitochondrial dysfunction, amyloid-beta, tau protein, neurofibrillary tangles, amyloid plaques, neurotoxicity, neurodegeneration, dementia
- MeSH terms
- Alzheimer Disease, Humans, Reactive Oxygen Species, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review